VIVS
VivoSim Labs, Inc.
$1.39
-1.42%
2026-05-08
About VivoSim Labs, Inc.
VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models; and bespoke services in the areas of investigational toxicology, mechanism of drug action elucidation, and other applications of complex human tissue models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at various stages of drug development; and uses its proprietary technologies to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. In addition, it offers 3D human tissue platform that develops novel human normal and disease models using high throughput systems, bioprinted, and flow/stretch capable 3D systems. The company was formerly known as Organovo Holdings, Inc. and changed its name to VivoSim Labs, Inc. in April 2025. VivoSim Labs, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
Key Fundamentals
P/E Ratio
0.80
EPS (TTM)
$1.76
ROE
-51.1%
Revenue Growth (YoY)
8.3%
Profit Margin
0.0%
Debt/Equity
18.28
Price/Book
0.83
Beta
1.41
Market Cap
$4.1M
Avg Volume (10D)
61K
Recent Breakout Signals
No recent breakout signals detected for VIVS.
Recent Price Range (60 Days)
60D High
$2.28
60D Low
$1.25
Avg Volume
81K
Latest Close
$1.39
Get breakout alerts for VIVS
Sign up for Breakout Scanner to receive daily notifications when VIVS triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
VivoSim Labs, Inc. (VIVS) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors VIVS daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. VIVS operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.